UCSF pediatric transplant recipients and donors celebrate and share experiences at the 19th Annual Chris Mudge UCSF Pediatric Transplant Picnic.
TID: 1 047 VID: 9
UCSF is the lead institution on a new seven-year, $17 million multicenter study to determine if certain immune system cells and/or a drug can be effective in improving and maintaining the long-term health of kidney transplant recipients.
To make follow-up care more accessible, UC San Francisco and Walgreens are collaborating to launch the first program in the country that provides blood pressure testing at no charge to living kidney donors.
MEDIA ADVISORY: UCSF Has Strong Presence in Second-Ever Meeting of World Transplant Congress in San Francisco
What: In 2006, more than 6,500 specialists in transplant medicine worldwide gathered for the first time in one location at the World Transplant Congress (WTC) in Boston. Eight years later, the WTC is convening again, this time in San Francisco.
UCSF Medical Center has the highest one-year survival rate in the nation, among institutions performing more than 20 adult lung transplants each year, according to data from the Scientific Registry of Transplant Recipients.
Organ-transplant recipients often reject donated organs, but a new, two-pronged strategy developed by UCSF researchers to specifically weaken immune responses that target transplanted tissue has shown promise.
Troy Super Sr. became the 3,000th person to receive a liver transplant at UCSF Medical Center on Dec. 13 and was able to be home in time for Christmas.
In her annual State of the University address, Chancellor Susan Desmond-Hellmann highlighted UCSF's investments in its research, education and patient care to meet the challenges ahead.
The 14th World Congress of the International Pancreas and Islet Transplant Association will convene in Monterey, Calif., sponsored by the Transplantation Society and experts from UC San Francisco.